Tag: earnings estimate revision

GW Pharmaceuticals PLC: A Pre-Earnings Preview

GW Pharmaceuticals PLC: A Pre-Earnings Preview

By Carly Forster GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) is a British bio-pharmaceutical company best known for its cannabis-based multiple sclerosis treatment, Sativex. GW Pharmaceuticals in the News GW Pharmaceuticals is scheduled to announce its Fiscal third quarter earnings report on Tuesday, […]